Holen Sie sich die Stockscreener-App
6.65
0.76%
0.05
Fennec Pharmaceuticals Inc Aktie (FENC) Neueste Nachrichten
Chris Anigeron Rallis Sells 1,186 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat
(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Above 50-Day Moving AverageHere's Why - MarketBeat
Fennec Pharmaceuticals director sells shares worth $8,088 By Investing.com - Investing.com Nigeria
Fennec Pharmaceuticals director sells shares worth $8,088 - Investing.com India
(FENC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells 10,000 Shares of Stock - MarketBeat
Rostislav Christov Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat
Fennec Pharmaceuticals Inc. - MENAFN.COM
Norgine introduces PEDMARQSI in Germany for pediatric cancer care - MSN
Stocks In Play: Fennec Pharmaceuticals Inc. By Baystreet.ca - Investing.com Canada
Fennec Pharmaceuticals director Raykov sells $66,600 in shares - MSN
Fennec Pharmaceuticals Announces Commercial Launch of Pedmarqsi in Germany - Marketscreener.com
Fennec Pharmaceuticals' Pedmarqsi Launched in Germany by Norgine Pharmaceuticals - Marketscreener.com
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany - The Manila Times
Fennec Pharmaceuticals Brief: Announcing Commercial Launch of PEDMARQSI In Germany - Marketscreener.com
Revolutionary Cancer Drug PEDMARQSI Now Available in Germany$273M Deal Potential - StockTitan
Insider Sell Alert: Rosty Raykov Sells 10,000 Shares of Fennec P - GuruFocus.com
Fennec Pharmaceuticals director Raykov sells $66,600 in shares By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Above 50-Day Moving AverageHere's What Happened - MarketBeat
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Short Interest Update - MarketBeat
Trend Tracker for (FENC) - Stock Traders Daily
Fennec PharmaA Sound Investment? - RTTNews
Fennec Pharmaceuticals (NASDAQ:FENC) shareholder returns have been respectable, earning 41% in 3 years - Simply Wall St
Fennec Pharmaceuticals (NASDAQ:FENC) versus CARGO Therapeutics (NASDAQ:CRGX) Financial Survey - Defense World
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Barclays PLC Raises Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Sees Large Decrease in Short Interest - MarketBeat
Learn to Evaluate (FENC) using the Charts - Stock Traders Daily
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$87,552.00 in Stock - MarketBeat
Barclays PLC Grows Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares By Investing.com - Investing.com Australia
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares - Investing.com
Franklin Resources Inc. Has $74,000 Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
State Street Corp Has $1.64 Million Stake in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Above 50 Day Moving AverageShould You Sell? - MarketBeat
Stocks In Play: Fennec Pharmaceuticals Inc. - Barchart
(FENC) Trading Advice - Stock Traders Daily
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):